A.forall Launches Tromethamine Injection 18GM/500mL in US with CGT Exclusivity
January 31, 2025
A.forall announced through its U.S. subsidiary, Milla Pharmaceuticals, that it has received Abbreviated New Drug Application (ANDA) approval by the U.S. Food and Drug Administration (FDA)